A Six-month, Randomized, Double-masked Study Comparing Latanoprost with Timolol in Open-angle Glaucoma and Ocular Hypertension
- 1 January 1996
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 103 (1), 126-137
- https://doi.org/10.1016/s0161-6420(96)30750-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol.British Journal of Ophthalmology, 1995
- The Effects on Aqueous Dynamics of PhXA41, a New Prostaglandin F2α Analogue, After Topical Application in Normal and Ocular Hypertensive Human EyesArchives of Ophthalmology (1950), 1993
- Intraocular Pressure-reducing Effect of PhXA41 in Patients with Increased Eye PressureOphthalmology, 1993
- Intraocular Pressure-reducing Effect of PhXA41 in Ocular HypertensionOphthalmology, 1993
- Phenyl-substituted prostaglandins: potent and selective antiglaucoma agentsJournal of Medicinal Chemistry, 1993
- Intraocular Pressure Reduction With PhXA34, a New Prostaglandin Analogue, in Patients With Ocular HypertensionArchives of Ophthalmology (1950), 1992
- PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension.British Journal of Ophthalmology, 1992
- Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2α-1-isopropylester in the cynomolgus monkeyExperimental Eye Research, 1989
- Autacoids and NeuropeptidesPublished by Springer Nature ,1984
- Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2αCurrent Eye Research, 1981